427 related articles for article (PubMed ID: 20844293)
41. Aspirin, other NSAIDs, and ovarian cancer risk (United States).
Fairfield KM; Hunter DJ; Fuchs CS; Colditz GA; Hankinson SE
Cancer Causes Control; 2002 Aug; 13(6):535-42. PubMed ID: 12195643
[TBL] [Abstract][Full Text] [Related]
42. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.
Huang WK; Chiou MJ; Yu KH; Lin YC; Yang TS; Chen JS; Kuo CF; See LC
Aliment Pharmacol Ther; 2013 Aug; 38(4):432-9. PubMed ID: 23799975
[TBL] [Abstract][Full Text] [Related]
43. Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry.
Resler AJ; Makar KW; Heath L; Whitton J; Potter JD; Poole EM; Habermann N; Scherer D; Duggan D; Wang H; Lindor NM; Passarelli MN; Baron JA; Newcomb PA; Le Marchand L; Ulrich CM
Carcinogenesis; 2014 Sep; 35(9):2121-6. PubMed ID: 24908683
[TBL] [Abstract][Full Text] [Related]
44. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
Trabert B; Ness RB; Lo-Ciganic WH; Murphy MA; Goode EL; Poole EM; Brinton LA; Webb PM; Nagle CM; Jordan SJ; ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Lurie G; Kjær SK; Hogdall E; Jensen A; Cramer DW; Terry KL; Vitonis A; Bandera EV; Olson S; King MG; Chandran U; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike MC; Berchuck A; Schildkraut JM; Wentzensen N;
J Natl Cancer Inst; 2014 Feb; 106(2):djt431. PubMed ID: 24503200
[TBL] [Abstract][Full Text] [Related]
45. Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents.
Greenberg ER; Baron JA
IARC Sci Publ; 1996; (139):91-8. PubMed ID: 8923021
[TBL] [Abstract][Full Text] [Related]
46. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer.
Shpitz B; Klein E; Buklan G; Neufeld D; Nissan A; Freund HR; Grankin M; Bernheim J
Gut; 2003 Nov; 52(11):1598-601. PubMed ID: 14570729
[TBL] [Abstract][Full Text] [Related]
47. Aspirin: still learning about the wonder drug.
Hawk ET; Viner JL
Gut; 2003 Nov; 52(11):1535-6. PubMed ID: 14570718
[No Abstract] [Full Text] [Related]
48. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.
Asgari MM; Maruti SS; White E
J Natl Cancer Inst; 2008 Jul; 100(13):967-71. PubMed ID: 18577752
[TBL] [Abstract][Full Text] [Related]
49. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
50. Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk.
Wang X; Chan AT; Slattery ML; Chang-Claude J; Potter JD; Gallinger S; Caan B; Lampe JW; Newcomb PA; Zubair N; Hsu L; Schoen RE; Hoffmeister M; Brenner H; Le Marchand L; Peters U; White E
Cancer Res; 2018 Aug; 78(16):4790-4799. PubMed ID: 29921691
[TBL] [Abstract][Full Text] [Related]
51. Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies.
Zaman FY; Orchard SG; Haydon A; Zalcberg JR
Br J Cancer; 2022 Nov; 127(10):1735-1743. PubMed ID: 35764787
[TBL] [Abstract][Full Text] [Related]
52. Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Tjønneland A; Pottegård A; Hallas J; Sørensen HT; Friis S
Cancer Causes Control; 2020 Feb; 31(2):139-151. PubMed ID: 31823168
[TBL] [Abstract][Full Text] [Related]
53. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study.
Smalley W; Ray WA; Daugherty J; Griffin MR
Arch Intern Med; 1999 Jan; 159(2):161-6. PubMed ID: 9927099
[TBL] [Abstract][Full Text] [Related]
54. Differences in risk factor-colorectal adenoma associations according to non-steroidal anti-inflammatory drug use.
Mujtaba S; Bostick RM
Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1318-1326. PubMed ID: 30161027
[TBL] [Abstract][Full Text] [Related]
55. NSAIDs and gastrointestinal cancer prevention.
Jolly K; Cheng KK; Langman MJ
Drugs; 2002; 62(6):945-56. PubMed ID: 11929340
[TBL] [Abstract][Full Text] [Related]
56. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
[TBL] [Abstract][Full Text] [Related]
57. Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.
Brasky TM; Liu J; White E; Peters U; Potter JD; Walter RB; Baik CS; Lane DS; Manson JE; Vitolins MZ; Allison MA; Tang JY; Wactawski-Wende J
Int J Cancer; 2014 Oct; 135(8):1869-83. PubMed ID: 24599876
[TBL] [Abstract][Full Text] [Related]
58. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
Brusselaers N; Lagergren J
BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219
[TBL] [Abstract][Full Text] [Related]
59. Aspirin for the prevention of colorectal cancer.
Garcia-Albeniz X; Chan AT
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):461-72. PubMed ID: 22122763
[TBL] [Abstract][Full Text] [Related]
60. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
Prostate; 2015 Sep; 75(13):1394-402. PubMed ID: 26073992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]